Clearview Wealth Advisors’s Twist Bioscience TWST Stock Holding History

Clearview Wealth Advisors’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-235	Closed	-$4.81K	–	597
2023 Q2	$4.81K	Hold	235	–	–	﹤0.01%	437
2023 Q1	$3.54K	Hold	235	–	–	﹤0.01%	463
2022 Q4	$5.59K	Hold	235	–	–	﹤0.01%	383
2022 Q3	$8K	Hold	235	–	–	0.01%	366
2022 Q2	$8K	Buy	+235	New	+$8.32K	0.01%	392

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Clearview Wealth Advisors's TWST Position: Q3 2023 in Review

Clearview Wealth Advisors sold out of Twist Bioscience (TWST) in Q3 2023, closing a stake of 235 shares — an estimated $4.81K sold.

Clearview Wealth Advisors first reported a position in TWST in Q2 2022 and held it in 5 quarters. The position peaked at $8K in Q3 2022. 194 funds tracked by Wall St. Rank hold TWST as of Q3 2023.

Clearview Wealth Advisors reported no remaining Twist Bioscience position as of Q3 2023 after selling out during the quarter.
Clearview Wealth Advisors sold 235 Twist Bioscience shares in Q3 2023, an estimated $4.81K.
Clearview Wealth Advisors first reported a position in Twist Bioscience in Q2 2022 and held it in 5 quarters.
Clearview Wealth Advisors's Twist Bioscience position peaked at $8K in Q3 2022.
194 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2023.

Based on Clearview Wealth Advisors's 13F filing for Q3 2023, filed 30 Oct 2023.